pd-117596 has been researched along with nalidixic acid in 3 studies
Studies (pd-117596) | Trials (pd-117596) | Recent Studies (post-2010) (pd-117596) | Studies (nalidixic acid) | Trials (nalidixic acid) | Recent Studies (post-2010) (nalidixic acid) |
---|---|---|---|---|---|
21 | 0 | 0 | 3,246 | 87 | 340 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, DL; Epling, GA; Kiely, JS; Robertson, DG; Song, B | 1 |
Hall, MC; Piddock, LJ; Walters, RN | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Smith, RP | 1 |
3 other study(ies) available for pd-117596 and nalidixic acid
Article | Year |
---|---|
Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antioxidants; Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Free Radical Scavengers; Hemolysis; Male; Mice; Mice, Inbred Strains; Nalidixic Acid; Nitroso Compounds; Oxygen; Photochemistry; Photolysis; Quinolones; Thiobarbiturates | 1991 |
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Mutation; Nalidixic Acid; Phenotype; Quinolones; Serratia marcescens; Species Specificity | 1991 |
In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Quinolones | 1988 |